Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (181-190 of 333) with videos related to

Pageof 34
Sort By:
Oncology Reports|December 6, 2005
Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapyM Schuchmann, H Schulze-Bergkamen, B Fleischer, et al.
BMC Cancer|April 18, 2015
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinomaArndt Weinmann, Yvonne Alt, Sandra Koch, et al.
The Lancet. Gastroenterology & Hepatology|March 19, 2023
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trialRohit Loomba, Manal F Abdelmalek, Matthew J Armstrong, et al.
Clinical and Translational Gastroenterology|July 29, 2022
Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver CirrhosisEva Maria Schleicher, Wolfgang Maximilian Kremer, Vasiliki Kalampoka, et al.
Journal of Hepatology|June 28, 2011
Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivoJörn M Schattenberg, Tim Zimmermann, Marcus Wörns, et al.
European Journal of Internal Medicine|May 25, 2010
Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD)Tim Zimmermann, Maria Hoppe-Lotichius, Vuk Tripkovic, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 16, 2012
Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIPJörn M Schattenberg, Michael Nagel, Yong Ook Kim, et al.
Archives of Public Health = Archives Belges De Sante Publique|August 23, 2024
Change of self-rated physical health predicts mortality in aging individuals: results of a population-based cohort studyAnna Celine Reinwarth, Felix S Wicke, Kamiar K Rückert, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 11, 2025
Gender-specific changes in vision-related quality of life over time - results from the population-based Gutenberg Health StudyAlica Hartmann, Stephanie D Grabitz, Philipp S Wild, et al.
Mediators of Inflammation|December 11, 2023
Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with CirrhosisLeonard Kaps, Carolina Medina-Montano, Matthias Bros, et al.
Pageof 34

Showing results (181-190 of 333) with videos related to

Sort By:
Pageof 34
Oncology Reports|December 6, 2005
Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapyM Schuchmann, H Schulze-Bergkamen, B Fleischer, et al.
BMC Cancer|April 18, 2015
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinomaArndt Weinmann, Yvonne Alt, Sandra Koch, et al.
The Lancet. Gastroenterology & Hepatology|March 19, 2023
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trialRohit Loomba, Manal F Abdelmalek, Matthew J Armstrong, et al.
Clinical and Translational Gastroenterology|July 29, 2022
Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver CirrhosisEva Maria Schleicher, Wolfgang Maximilian Kremer, Vasiliki Kalampoka, et al.
Journal of Hepatology|June 28, 2011
Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivoJörn M Schattenberg, Tim Zimmermann, Marcus Wörns, et al.
European Journal of Internal Medicine|May 25, 2010
Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD)Tim Zimmermann, Maria Hoppe-Lotichius, Vuk Tripkovic, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 16, 2012
Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIPJörn M Schattenberg, Michael Nagel, Yong Ook Kim, et al.
Archives of Public Health = Archives Belges De Sante Publique|August 23, 2024
Change of self-rated physical health predicts mortality in aging individuals: results of a population-based cohort studyAnna Celine Reinwarth, Felix S Wicke, Kamiar K Rückert, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 11, 2025
Gender-specific changes in vision-related quality of life over time - results from the population-based Gutenberg Health StudyAlica Hartmann, Stephanie D Grabitz, Philipp S Wild, et al.
Mediators of Inflammation|December 11, 2023
Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with CirrhosisLeonard Kaps, Carolina Medina-Montano, Matthias Bros, et al.
Pageof 34